Company intelligence / Profile preview

Opal Bio Pharma

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Opal Bio Pharma is an Oman-based biopharmaceutical company established in 2022. It specializes in developing cost-effective biosimilar mAbs/biologics, high-tech vaccines addressing global shortages, advanced gene-modified cell therapies including CAR-T/TCR-T/NK cells/stem cells as well as in vivo gene therapy approaches. The company's mission is to improve healthcare accessibility across the Arab world and middle-income countries by producing affordable biologics/vaccines using cutting-edge manufacturing technologies. No published clinical results are available as of now.[1][3][6]

Therapeutic areas: Immunology
Modalities: Biosimilar monoclonal antibodies (mAbs)Antibody-drug conjugates (ADCs)Fusion proteinsIn vivo gene therapies (AAV, lentivirus, CRISPR, mRNA-based)[1]Gene-modified cell therapies (CAR-T, TCR-T, engineered NK/Tregs, hematopoietic stem cell therapies)[1]Vaccines[3][4][6]
Industry: Biotech

Drug pipeline

4 assets

OBP-2201

Preclinical

3 more assets in the full pipeline.

Request access →

Partnerships

Collaborations with governments and NGOs for awareness/prevention campaigns; no major pharma partnerships disclosed yet.[6]

Beyond the preview

Go deeper on Opal Bio Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Opal Bio Pharma.

Explore the full profile